Market Gazer Hong Kong - Japan - Germany - UK - North America
market review : europe was also rumored to be bought be AT&T,
European markets stayed on bullish
course while the North American market
was shut down for Labor Day holiday on
Monday. German DAX index advanced
20.42 points higher or 0.33% to 6,155.04,
FTSE 100 also up 11.04 points or 0.20% to
5,439.19.
Barclays Plc was
said to create up
to 600 jobs in
Glasgow,
Scotland. In turn, the Scottish government
would provide the bank a grant of about
6.6 million pounds on the condition that
Barclays would take its total workforce in
Scotlandto more than 2,000 in the coming
years. The expansion will include a new
facility for its investment banking and
wealth management division. On Monday,
Barclays finished at 322.85 pence or down
0.66%.
BP Plc. increased its target of asset sales
to $40 billion from $30 billion. According
to the Sunday Times, the proceeds will be
used to pay the bills of the cleanup in the
Gulf of Mexico. BP advanced 1.19% to
406.50 pence.
BT Group gained
2.18% to 140.60
pence after the
news from The Independent said that
Singapore Telecommunications Ltd. is
approaching to acquire its rival, Cable &
Wireless Worldwide Plc. Recently, C&W
6 September 2010
but AT&T declined to comment.
Would Deutsche Telekom AG merge with
France Telecom? The CFE-CGC/UNSA
labor union federation thought that it was
a possibility. The union pointed at the
Deutsche Bank increasing its stakes in
France Telecom to more than 5% as a
signal to such move by the Deutsche
Telekom. No confirmation yet on this
speculation, but the union is planning to
meet with the France Telecom’s
management to discuss this matter.
Deutsche Bank was at €50.16, up 0.30%,
while Deutsche Telekom inched 0.05%
higher at €10.37.
ThyssenKrupp, the
German-based
steelmaker and
engineering company
said that it would
raise steel prices by €30/ton starting from
October. Shares of ThyssenKrupp rose
0.95% to €22.77.
GlaxoSmithKline Plc. fell after British
Medical Journal urged Glaxo to withdraw
Avandia diabetes treatment as the drug
was seen to have more risks than
benefits. European Medicines Agency is to
meet on Sept 8th to discuss the drug’s
safety. GSK fell 1.54% to 1,249 pence.
Disclaimer: This report is provided for information purposes
only. It is not an offer to sell or to buy any securities. This
report has been prepared based on sources believed to be
reliable, but there is no assurance or guarantee regarding its
completeness & and accuracy. None of ATF Capital accepts any
responsibility or liability arising from any use of the report.
Neither ATF Capital nor the author at the moment of writing
has interest in any of the securities mentioned in the report.
Page 1